Page last updated: 2024-12-08
gelsenicine
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
gelsenicine: an analgesic isolated from Gelsemium elegans; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Related Flora
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Gelsemium | genus | A plant genus of the family LOGANIACEAE (classified by some botanists as Gelsemiaceae). The sometimes used common name of trumpet flower is also used for DATURA.[MeSH] | Gelsemiaceae | [no description available] |
Cross-References
ID Source | ID |
---|---|
PubMed CID | 158212 |
MeSH ID | M0572295 |
Synonyms (5)
Synonym |
---|
gelsenicine |
gelsedine, 4,20-didehydro- |
(1r,2s,4s,8s)-6-ethyl-1'-methoxyspiro[10-oxa-5-azatricyclo[5.3.1.04,8]undec-5-ene-2,3'-indole]-2'-one |
D85047 |
DTXSID601002625 |
Research Excerpts
Toxicity
Excerpt | Reference | Relevance |
---|---|---|
"Gelsenicine is one of the most toxic compounds in the genus Gelsemium, but the mechanism of toxicity is not clear." | ( Phosphoproteomics reveals NMDA receptor-mediated excitotoxicity as a key signaling pathway in the toxicity of gelsenicine. Huang, CY; Huang, SJ; Liu, ZY; Qi, XJ; Zuo, MT, 2021) | 2.28 |
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" However, Gelsemium is a known toxic plant, and its toxicity limits its appropriate dosage and clinical use." | ( Gelsemium analgesia and the spinal glycine receptor/allopregnanolone pathway. Wang, YX; Zhang, JY, 2015) | 0.42 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (15)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (46.67) | 24.3611 |
2020's | 8 (53.33) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 21.24
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.24) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (6.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 14 (93.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |